NVAX

Novavax Inc (NVAX)

US
$ 6.7050.52%

Price Chart

Key Statistics

Market Cap
$ 965.34M
P/E Ratio
2.17
Revenue (TTM)
$ 1.25B
Volume
5.45M
52W High
$ 23.86
52W Low
$ 5.01
Dividend Yield
0.00%
Beta
3.21

Technicals

50-Day MA
6.851
200-Day MA
9.3289
52 Week High
23.8599
52 Week Low
5.01

About NVAX

Novavax, Inc., a biotechnology company, engages in the discovering, developing, and commercializing vaccines to protect against serious infectious diseases in the United States, Europe, and internatio.

Employees
952
Headquarters
Gaithersburg, MD
CEO
Mr. John Charles Jacobs M.B.A.

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name
LTP
% Chg

Top Losers

Symbol/Name
LTP
% Chg